Hurşit Ferahkaya

Dr. Hurşit Ferahkaya

orcid

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 January 2023 in Nordic Journal of Psychiatry
Verified
Journal Article
Closed access
ABAyhan Bilgiç
Ayhan Bilgiç
HFHurşit Ferahkaya
Hurşit Ferahkaya
HKHülya Karagöz
Hülya Karagöz
IKİbRahim Kılınç
İbRahim Kılınç
VEVesile Meltem Energin
Vesile Meltem Energin
Increased intestinal and blood-brain barriers (BBB) permeability has been suggested to have a role in autism spectrum disorder (ASD). Claudin-5, claudin-11, occludin, β-catenin, vinculin, and paxil...

8 June 2025 in Psychiatry Research
Verified
Journal Article
Closed access
EEEyüp Sabri Ercan
Eyüp Sabri Ercan
ABAyhan Bilgiç
Ayhan Bilgiç
ATAli Evren Tufan
Ali Evren Tufan
ÖAÖmer Faruk Akça
Ömer Faruk Akça
İYİpek Perçinel Yazıcı
İpek Perçinel Yazıcı
SÖSüleyman Emre Özyürek
Süleyman Emre Özyürek

6 October 2023 in The European Journal of Psychiatry
Verified
Journal Article
Closed access
HFHurşit Ferahkaya
Hurşit Ferahkaya
ÖAÖmer Faruk Akça
Ömer Faruk Akça
TBTamer Baysal
Tamer Baysal
IKİbRahim Kılınç
İbRahim Kılınç

1 January 2023 in Journal of Clinical Psychopharmacology
Verified
Journal Article
Closed access
SESemih Erden
Semih Erden
HFHurşit Ferahkaya
Hurşit Ferahkaya

10 February 2021 in Clinical Neuropharmacology
Verified
Journal Article
Closed access
HFHurşit Ferahkaya
Hurşit Ferahkaya
ABAyhan Bilgiç
Ayhan Bilgiç
Children with autism spectrum disorder frequently exhibit inappropriate sexual behaviors, such as excessive masturbation. However, research on the control and management of excessive masturbation in these children is very limited. In this presentation, excessive masturbation that responded to treatment with methylphenidate is described in a young boy diagnosed with autism spectrum disorder and comorbid attention deficit hyperactivity disorder.

24 May 2021 in Journal of Contemporary Medicine
Verified
Journal Article
Closed access
PDF file
HFHurşit Ferahkaya
Hurşit Ferahkaya
ÖAÖmer Faruk Akça
Ömer Faruk Akça
Attention-deficit/hyperactivity disorder is a common neurodevelopmental disorder in childhood, for which there are several different treatment options. Among the suggested medications, methylphenidate (a central nervous system stimulant) is the first option in the treatment of ADHD. Psychostimulants are associated with various vascular problems including peripheral vasculopathy. This report describes two patients with ADHD who developed Raynaud's phenomenon during the modified-release methylphenidate treatment.